Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Rades, Dirk; Bartscht, Tobias; Hunold, Peter et al.
Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)STRAHLENTHERAPIE UND ONKOLOGIE. Bd. 196. H. 9. 2020 S. 795-804
Kudo, Masatoshi; Galle, Peter R.; Llovet, Josep M. et al.
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2LIVER INTERNATIONAL. Bd. 40. H. 8. 2020 S. 2008-2020
Zhu, Andrew X.; Ikeda, Masafumi; Galle, Peter R. et al.
Ramucirumab in patients with advanced HCC and elevated alpha-fetoprotein (AFP): Outcomes by treatment-emergent ascites.JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 15. 2020
Finn, R. S.; Qin, S-K.; Galle, P. R. et al.
Ramucirumab in patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: An expansion cohort of the phase III REACH-2 studyANNALS OF ONCOLOGY. Bd. 31. 2020 S. S702-S702
Harter, P.; Sehouli, J.; Meier, W. et al.
Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer - final analysis of AGO DESKTOP III/ENGOT-ov20GEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 80. H. 10. 2020 S. E79-E79
Huettl, F.; Lang, H.; Paschold, M. et al.
Rating of camera navigation skills in colorectal surgeryINTERNATIONAL JOURNAL OF COLORECTAL DISEASE. Bd. 35. H. 6. 2020 S. 1111-1115
Zumla, Alimuddin; Wang, Fu-Sheng; Ippolito, Giuseppe et al.
Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapiesINTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. Bd. 96. 2020 S. 431-439
Moehler, Markus H.; Stein, Alexander; Trojan, Jorg et al.
Regorafenib with TAS-102 (REGOTAS) in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY)JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020
Moehler, M.; Stein, A.; Trojan, J. et al.
Regorafenib with TAS-102 in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY)ANNALS OF ONCOLOGY. Bd. 31. 2020 S. S214-S214
Bartsch, Fabian; Hahn, Felix; Mueller, Lukas et al.
Relevance of suspicious lymph nodes in preoperative imaging for resectability, recurrence and survival of intrahepatic cholangiocarcinomaBMC SURGERY. Bd. 20. H. 1. 2020